| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 89.3K | $96.4K | $2.62 | Jun 3, 2025 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Director | Common Stock | 85.2K | $43.4K | $0.51 | May 13, 2025 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 104K | Jun 3, 2025 | Direct | ||
| Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | Jun 16, 2023 | Direct | |
| Prometheus Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | Jun 16, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Jun 3, 2025 | 2 | $0 | 4 | Jun 3, 2025 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | May 13, 2025 | 2 | $0 | 4 | May 13, 2025 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | May 13, 2024 | 2 | $0 | 4 | May 13, 2024 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Apr 28, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
| RXDX | Prometheus Biosciences, Inc. | Jun 16, 2023 | 3 | $0 | 4 | Jun 16, 2023 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | May 21, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
| RXDX | Prometheus Biosciences, Inc. | May 19, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Apr 28, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | May 21, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
| RXDX | Prometheus Biosciences, Inc. | May 19, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Apr 30, 2022 | 2 | $0 | 4 | May 2, 2022 | Director |